Synergism between mycophenolate mofetil and cyclosporine in preventing graft-versus-host disease among lethally irradiated dogs given DLA-nonidentical unrelated marrow grafts.
暂无分享,去创建一个
H. Deeg | R. Storb | B. Sandmaier | C. Yu | R. Nash | A. Barsoukov | K. Seidel | E. Santos | C. Yu | C. Yu
[1] H. Deeg,et al. Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation. , 1997, Blood.
[2] H. Sollinger. Update on preclinical and clinical experience with mycophenolate mofetil. , 1996, Transplantation proceedings.
[3] R. Storb,et al. Molecular analysis of DLA-DRBB1 polymorphism. , 1996, Tissue antigens.
[4] E. Ostrander,et al. Histocompatibility testing of dog families with highly polymorphic microsatellite markers. , 1996, Transplantation.
[5] H. Deeg,et al. Allogeneic transplants of canine peripheral blood stem cells mobilized by recombinant canine hematopoietic growth factors , 1996 .
[6] J. Anthony,et al. Use of combination of low-dose cyclosporine and RS-61443 in a rat hindlimb model of composite tissue allotransplantation. , 1996, Transplantation.
[7] P. Halloran,et al. Molecular mechanisms of new immunosuppressants. , 1996, Clinical transplantation.
[8] H. Sollinger. From mice to man: the preclinical history of mycophenolate mofetil. , 1996, Clinical transplantation.
[9] J Wagner,et al. Preclinical large animal models for hematopoietic stem cell transplantation , 1996, Current opinion in hematology.
[10] H. Deeg,et al. Prevention of Graft‐versus‐Host Disease , 1995, Annals of the New York Academy of Sciences.
[11] H. Deeg,et al. DLA-identical bone marrow grafts after low-dose total body irradiation: effects of high-dose corticosteroids and cyclosporine on engraftment. , 1995, Blood.
[12] H. Deeg,et al. Corticotropin releasing factor with or without methotrexate for prevention of graft-versus-host disease in DLA-nonidentical unrelated canine marrow grafts. , 1995, Transplantation.
[13] R A Nash,et al. Tacrolimus (FK506) alone or in combination with methotrexate or methylprednisolone for the prevention of acute graft-versus-host disease after marrow transplantation from HLA-matched siblings: a single-center study. , 1995, Blood.
[14] E. Bryant,et al. USE OF (CA)n POLYMORPHISMS TO DETERMINE THE ORIGIN OF BLOOD CELLS AFTER ALLOGENEIC CANINE MARROW GRAFTING , 1994, Transplantation.
[15] B. Sandmaier,et al. 'Resistance' to unrelated, DLA-nonidentical canine marrow grafts is unrestricted by the major histocompatibility complex. , 1994, Experimental hematology.
[16] H. Deeg,et al. FK‐506 AND METHOTREXATE PREVENT GRAFT‐VERSUS-HOST DISEASE IN DOGS GIVEN 9.2 Gy TOTAL BODY IRRADIATION AND MARROW GRAFTS FROM UNRELATED DOG LEUKOCYTE ANTIGEN‐NONIDENTICAL DONORS , 1993, Transplantation.
[17] B. Sandmaier,et al. Enhancement of natural killer activity by an antibody to CD44. , 1993, Journal of immunology.
[18] A. Allison,et al. Bone marrow dysfunction in irradiated, cytomegalovirus-infected mice. , 1991 .
[19] A. Allison,et al. Lymphocyte-selective antiproliferative and immunosuppressive activity of mycophenolic acid and its morpholinoethyl ester (RS-61443) in rodents. , 1991, Transplantation proceedings.
[20] K. Lafferty,et al. Tolerance induction in adult animals: comparison of RS-61443 and anti-CD4 treatment. , 1991, Transplantation proceedings.
[21] D. Eckhoff,et al. RS-61443--a new, potent immunosuppressive agent. , 1991, Transplantation.
[22] A. Allison,et al. In vitro immunosuppressive effects of mycophenolic acid and an ester pro-drug, RS-61443. , 1991, Transplantation proceedings.
[23] W. Ladiges. 4 – Experimental Techniques Used to Study the Immune System of Dogs and Other Large Animals , 1989 .
[24] H. Deeg,et al. Role of radiation-resistant large granular lymphocytes in the rejection of unrelated DLA-nonidentical marrow grafts in dogs. , 1987, Transplantation proceedings.
[25] H. Deeg,et al. FAILURE OF ALLOGENEIC CANINE MARROW GRAFTS AFTER TOTAL‐BODY IRRADIATION: ALLOGENEIC “RESISTANCE” VERSUS TRANSFUSION‐INDUCED SENSITIZATION , 1986, Transplantation.
[26] H. Deeg,et al. Prevention of graft-versus-host disease by immunosuppressive agents after transplantation of DLA-nonidentical canine marrow. , 1986, Bone marrow transplantation.
[27] H. Deeg,et al. Marrow transplantation for severe aplastic anemia: methotrexate alone compared with a combination of methotrexate and cyclosporine for prevention of acute graft-versus-host disease. , 1986, Blood.
[28] H. Deeg,et al. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. , 1986, The New England journal of medicine.
[29] W. Sadee,et al. Biochemical differences among four inosinate dehydrogenase inhibitors, mycophenolic acid, ribavirin, tiazofurin, and selenazofurin, studied in mouse lymphoma cell culture. , 1985, Cancer research.
[30] H. Deeg,et al. CYCLOSPORIN A AND METHOTREXATE IN CANINE MARROW TRANSPLANTATION: ENGRAFTMENT, GRAFT‐VERSUS-HOST DISEASE, AND INDUCTION OF TOLERANCE , 1982, Transplantation.
[31] H. Ochs,et al. Immunologic Reactivity in Canine Marrow Graft Recipients , 1974, The Journal of Immunology.